immune-system

Documents about immune-system

• Behavioral Inhibition in Rhesus Monkeys (Macaca mulatta) Is Related to the Airways Response, but Not Immune Measures, Commonly Associated with Asthma#612107eScholarship
• Estudo sobre ocorrências de infecções em atletas e não atletas - Imunolab Study - Fisex FEF-UNICAMP#206649Repositório de Dados de Pesquisa da Unicamp Dataverse OAI Archive
• Improving HIV Screening With Nurse-Based Rapid Testing/Streamlined Counseling#807099ClinicalTrials.gov
• Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune System#813024ClinicalTrials.gov
• Impact of Vitamin A on Multiple Sclerosis (MS)#863761ClinicalTrials.gov
• Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis#883337ClinicalTrials.gov
• Prenatal Antibiotics and Breast Milk / Neonatal IgA#969594ClinicalTrials.gov
• Longitudinal Changes in Plasma Biomarkers of Immune Activation, Neuronal Inflammation and Injury in Persons With HIV Initiating ART#200795ODU Digital Commons
• Decoding Organizational Silence and Signal Loss: A Living Systems Metaphor for Perception and Learning#343151Figshare
• Effects on the immune system of a three-month consumption of an extremely diverse probiotic yogurt: decrease of serum alpha-N-acetylgalactosaminidase activity, detoxification and gut microbiota normalization#486926NutriXiv
• Effects of Ofatumumab Treatment on Immune Cells and Meningeal Lymphatic Drainage in Patients With Demyelinating Diseases#901188ClinicalTrials.gov
• Insights into interstitial lung disease pathogenesis.#628426Apollo
• The Grounded Brain: How Sleeping Grounded Affects Memory and Perceptions#851270ClinicalTrials.gov
• Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 704/HPTN 085 AMP Study#872027ClinicalTrials.gov
• Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRU#1033491ClinicalTrials.gov
• A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)#842041ClinicalTrials.gov
• Comparative effectiveness of first-line anti-PD-1 versus cetuximab in advanced cutaneous squamous cell carcinoma: A nationwide population-based study using the French national health data system#215412HAL (France)
• Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant#850972ClinicalTrials.gov
• Data for Type I Restriction–Modification Systems Regulate Gene Expression through DNA Topology#681867AMS Acta
• Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older#910143ClinicalTrials.gov
• A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists#911432ClinicalTrials.gov
• An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease#1010810ClinicalTrials.gov
• Central memory CD4+ T cells are preferential targets of double infection by HIV-1 Retroviruses#220231UNSWorks Repository
• Dietary Cholesterol and Defects in Cholesterol Synthesis in Mevalonate Kinase Deficiency#912499ClinicalTrials.gov
• Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy#834507ClinicalTrials.gov
• Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL#884687ClinicalTrials.gov
• Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System#896235ClinicalTrials.gov
• Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes#676008eScholarship
• A Post-marketing, Blinded Study to Investigate How Effective Fidaxomicin is Compared to Vancomycin in the Sustained Cure of Clostridium Difficile Infection in Adults That Are Receiving Therapy to Suppress the Immune System#829496ClinicalTrials.gov
• A Study of KW-2478 in Combination With Bortezomib in Subjects With Relapsed and/or Refractory Multiple Myeloma#900944ClinicalTrials.gov
• Plasma proteomics defines two reproducible subphenotypes of sepsis-associated acute kidney injury with distinct outcomes#675935eScholarship
• A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease#857601ClinicalTrials.gov
• Inflammatory response of disc cells against Propionibacterium acnes depends on the presence of lumbar Modic changes#614699eScholarship
• PTPN22-CD45 dual phosphatase retrograde feedback enhances TCR signaling and autoimmunity#675979eScholarship
• A Study of Ponatinib in Japanese Participants With Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)#835690ClinicalTrials.gov
• Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects#837382ClinicalTrials.gov
• Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant#833919ClinicalTrials.gov
• Extracellular DNA, Neutrophil Extracellular Traps, and Inflammasome Activation in Severe Asthma#996278eScholarship
• Mitohormesis reprogrammes macrophage metabolism to enforce tolerance#642078eScholarship
• LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling#675850eScholarship
• A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes#982495ClinicalTrials.gov
• Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.#846389ClinicalTrials.gov
• A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)#839456ClinicalTrials.gov
• THE PHYSICAL AND PSYCHOLOGICAL BENEFITS OF PARTICIPATING IN SPORTS#394066Zenodo (CERN)
• Contemporary dialogues in health sciences#928238Repositório Institucional da UFMG